GlassScriptPhysician profile
Laurie Harris
NPI 1215375191
$6,705.16
in general payments reported to CMS, 2019-2025
44 companies · $1,012 in 2025
The $1,012 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $618 · 2021: $775 · 2022: $792 · 2023: $1,687 · 2024: $1,207 · 2025: $1,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,906.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $979.87 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $945.28 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $784.74 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $534.13 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $360.78 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $344.83 | 2019-2025 | Veozah |
| Amgen INC. | $342.83 | 2019-2025 | Repatha, Otezla, Otezla |
| Janssen Pharmaceuticals, INC | $342.22 | 2021-2025 | Xarelto, Spravato |
| Pfizer INC. | $336.99 | 2019-2025 | |
| Glaxosmithkline, LLC. | $242.44 | 2019-2025 | Shingrix, Arexvy |
| Insightec,INC | $147.06 | 2023-2024 | Exablate |
| Dexcom, INC. | $118.25 | 2021-2023 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $107.24 | 2019-2021 | |
| Exact Sciences Corporation | $97.46 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $95.55 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurie Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.